litigation

News

Novartis bid to block generic Entresto in US suffers setback

An appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic of its heart failure blockbuster Entresto.

News

BMS files legal challenge to HHS' 340B rebate decision

Bristol-Myers Squibb has become the latest pharma in the US to file a legal challenge to a block on a 340B drug rebate model opposed by HRSA.

News

Pharmas ask appeals court to reconsider IRA lawsuits

The pharma industry's challenge to Medicare drug price negotiation powers continues to rumble on, with three drugmakers asking a US appeals court to revive their lawsuits.

News

Apple wins in Masimo lawsuit, but it's a shallow victory

The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal win for the tech giant – but failed to achieve its objectives.

News

Closeup of vials on a conveyor at Amgen facility

Legal win leads Amgen to at-risk launch of Eylea biosimilar

Amgen has chalked up a victory in a patent infringement lawsuit with Regeneron over blockbuster ophthalmic drug Eylea and decided to launch its biosimilar in the US – even though the legal

News

GSK turns its guns on Moderna in mRNA jab patent dispute

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV).

Novartis bid to block generic Entresto in US suffers setback

BMS files legal challenge to HHS' 340B rebate decision

Pharmas ask appeals court to reconsider IRA lawsuits

Apple wins in Masimo lawsuit, but it's a shallow victory

Legal win leads Amgen to at-risk launch of Eylea biosimilar

GSK turns its guns on Moderna in mRNA jab patent dispute

CHMP decision levels the playing field for GSK's RSV jab

How to meet your physicians where they are online

litigation

Editor's Picks